Endocrine Society Urges Congress to Avert Proposed Medicare Physician Payment Cuts

On July 7, the Center for Medicare and Medicaid Services (CMS) released the annual Medicare Physician Fee Schedule (MPFS) proposed rule. This rule outlines the agency’s proposed payment and quality program policies for the upcoming year.

This year’s rule proposes several important policy changes including allowing data collection on important telehealth services provided during the pandemic, revisions to reporting evaluation and management (E/M) services, and new codes proposed for billing the FDA-approved 180-day glucose sensor system. The rule also includes a 4.5% scheduled cut to the conversion factor. The Society is very concerned about this cut and is urging Congress to take action to avert it.

Every year, CMS requests our feedback on their proposed changes, and we respond by submitting a comment letter to the agency. Comments are due on September 7, 2022. We have worked with our Clinical Affairs Core Committee (CACC) and other Endocrine Society members with expertise in telehealth and quality payment issues.

If you are interested in learning more about this rule, you can visit the physician payment page on our website where you can find a one-pager and detailed summary of the rule. In addition, we will host a special Physician Payment Webinar in October to explain the impact of the proposed rule and how you can join our advocacy efforts to avert cuts.

You may also like

  • Advocacy In Action – July 2025

    Congress Considers President’s Budget, NIH Funding   In May, the federal budget process for fiscal year 2026 (FY 2026) kicked off in earnest as the White House Office of Management and Budget released the President’s Budget Request (PBR) for the coming year. The PBR calls for an overall 22% cut in non-defense discretionary spending and drastic…

  • May 2025 – Endocrine Society Advocacy In Action

    Endocrine Society is Advocating for You   We know this has been an extraordinary turbulent and disruptive time for U.S. researchers and our colleagues around the world. Since January, there have been a myriad of U.S. executive actions affecting researchers, including cuts to research, firing of federal workers, rescinded grants, and withdrawn funding opportunities. In early…

Find more in